Verzeichnis wissenschaftlicher Arbeiten

More documents

Recommendations

Info

12.) Brehm BR, Meergans M, Axel DI, Pfohl M, Heinle H, Karsch KR. Downregulation of �adrenergic receptors by low density lipoproteins and its prevention by �-adrenergic receptor antagonists. Cardiovasc Res 1998, 38: 522-530 13.) Brehm BR, Karsch KR. Characterization of �1- and �2-adrenergic receptors in the media of porcine coronary arteries. Perfusion 1999, 12: 126-132 14.) Wolf SC, Brehm BR, Gaschler F, Brehm S, Klaussner M, Smykowski J, Amann K, Osswald H, Erley CM, Risler T. Protective effects of endothelin antagonists in chronic renal failure. Nephrol Dial Transplant 1999, 99: 1010-1093 15.) Brehm BR, Bertsch D, von Fallois J, Wolf SC. �-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells. J Cardiovasc Pharmacol 2000, 36 (Suppl. 1): S401-S403 16.) Brehm BR, Heinle H, Risler T, Wolf SC. Chronically elevated endothelin-1 concentrations modulate the �-adrenergic receptor system in vitro and in vivo. J Cardiovasc Pharmacol 2000, 36 (Suppl. 1): S157-S159 17.) Wolf SC, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T, Brehm BR. Endothelin-receptor antagonists in uremic cardiomyopathy. J Cardiovasc Pharmacol 2000, 36 (Suppl): 348-350 18.) Brehm BR, Bock C, Wesselborg S, Pfeiffer S, Schüler S, Schulze-Osthoff K. Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan. Biochem Pharmacol 2001, 61: 119-127 19.) Brehm BR, Wolf SC, Bertsch D, Klaussner M, Wesselborg S, Schüler S, Schulze- Osthoff K. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Cardiovasc Res 2001, 49: 430-439 20.) Hahn U, Konig CW, Miller S, Brehm B, Heuschmid M, Kopp AF, Claussen CD. Multidetector CT Angiography - is it a valuable screening tool to detect significant renal artery stenosis. Röfo 2001, 173: 1086-1092 21.) Brehm BR, Wolf SC, Görner S, Buck-Müller N, Risler T. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study. Eur J Heart Fail 2002, 4: 757-63 22.) Brehm BR, Klaussner M, Wolf SC. Chronic elevated endothelin-1 concentrations regulate mitogen-activated protein kinases ERK 1 and ERK 2 in vascular smooth muscle cells. Clin Sci (Lond) 2002, 103 (Suppl) 48: 137S-140S 23.) Langer P, Bartsch D, Gerdes B, Schwetlick I, Wild A, Brehm B, Erley C, Lamberts R. Renin producing neuroendocrine pancreatic carcinoma - a case report and review of the literature. Exp Clin Endocrinol Diabetes 2002, 110: 43-49 24.) Brehm BR, Wolf SC, Freudenberg J, Friedmann F, Heinle H, Schulze-Osthoff K. Modulation of the beta-adrenergic receptor system of vascular smooth muscle cells in vitro and in vivo by chronically elevated endothelin-1 levels. Biochem Pharmacol 2002, 63: 1361- 1369
25.) Wolf SC, Amend T, Risler T, Amann K, Brehm BR. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy. Clin Sci (Lond) 2002, 103 (Suppl) 48: 276S-279S 26.) Wolf SC, Mayer O, Jürgens S, Vontheim R, Schultze G, Risler T, Brehm BR. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003, 59: 273-279 27.) Kastrup A, Gröschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stoke 2003, 34: 813-819 28.) Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR. Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure. Med Klin (Munich) 2003, 98: 1-6 29.) Wolf SC, Brehm BR, Mayer O, Jürgens S, Schultze G, Risler T. Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients - Chlamydia pneumoniae but not helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein. Ren Fail 2004, 26: 279-87 30.) Sauter G, Wolf S, Risler T, Brehm B. Influence of endothelin receptor antagonism on smooth muscle cell proliferation after chronic renal failure. J Cardiovasc Pharmacol 2004, 44 (Suppl): S165-167 31.) Sabine C. Wolf SC, Schultze M, Sauter G, Risler T, Lang F, Brehm BR. Endothelin-1 increases serum-glucose-regulated kinase-1 expression in smooth muscle cells. J Cardiovasc Pharmacol 2004, 44 (Suppl): S304-306 32.) Wolf SC, Brodbeck C, Sauter G, Risler T, Brehm BR. Endothelin-1 regulates protein kinase C isoforms differently in smooth muscle cells and in cardiomyocytes. J Cardiovasc Pharmacol 2004, 44 (Suppl): S301-303 33.) Wolf SC, Sauter G, Rodemann HP, Risler T, Brehm BR. Uremia increases growthfactor-induced proliferation of vascular smooth muscle cells – effects of endothelin and angiotensin II receptor antagonism. Nephrol Dial Transplant 2005, 20: 312-318 34.) Wolf SC, Sauter G, Brehm BR. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats. Ren Fail 2005, 27: 465-474 35.) Kempf VA, Lebiedziejewski M, Alitalo K, Walzlein JH, Ehehalt U, Fiebig J, Huber S, Schutt B, Sander CA, Müller S, Grassl G, Yazdi AS, Brehm B, Autenrieth IB. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 2005, 111: 1064-62 36.) Sauter G, Kreutzer U, Risler T, Brehm BR, Sabine C. Wolf. Effekte von ß-Rezeptor- Antagonisten auf die CRP vermittelte Expression von Entzündungsmarkern. Perfusion 2005, 18: 236-240
Page 1: Verzeichnis wissenschaftlicher Arbe
Page 5 and 6: 49.) Jung C, Fischer N, Fritzenwang

Verzeichnis wissenschaftlicher Arbeiten

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?